CO2 laser; hyperkeratosis; leukoplakia; oral surgery; premalignant lesions; white lesions; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Laser Therapy/methods; Leukoplakia, Oral/surgery; Longitudinal Studies; Male; Middle Aged; Treatment Outcome; CO2-laser; Laser Therapy; Leukoplakia, Oral; Biomedical Engineering; Radiology, Nuclear Medicine and Imaging
Abstract :
[en] [en] PURPOSE: The aim of this study was to evaluate the long-term success rate of oral leukoplakia treatments by using different laser-supported surgical protocols.
PATIENTS AND METHODS: Overall, 2347 diagnosed homogeneous oral leukoplakias were treated with CO2 laser and were included in this study. Different surgical protocols (P) were used: P1 (SV = superficial scanning) was a complete superficial vaporization of the leukoplakia by a scanning mode in two passages respecting an overlapping. Only the visible white area was treated in one surgical session independently of the lesion size. P2 (CR1x1) was a complete excision of the lesions until a tissular depth of 1 mm and 1 mm of surrounding healthy-like tissue were attained. The visible white area was treated in one surgical session independently of the lesion size. P3 (CR1x3) was a complete excision of the lesions until a minimum tissue depth of 1 mm and 3 mm of surrounding healthy-like tissue were obtained. The visible white area was treated in one surgical session independently of the lesion size. P4 (PR1x3) was similar to the third one, but for patient comfort, the large lesions of leukoplakias (lesion size higher than 20 mm), the complete surgical excision of the leukoplakia was performed in multiple sessions that were spaced by 1 month (partial surgical removal of 10 mm per session). All patients were recalled at 2 and 8 weeks after surgery, and then every 2 months during the first year, every 4 months during the second year, and once a year for the follow-up period of 6 years. A biopsy was done once a year during the follow-up period in the surgical site when needed. The control consisted of checking the nature and the aspect of the healed mucosa to exclude an eventual recurrence of leukoplakia.
RESULTS: The percentage of permanent success after 6 years of follow-up was 5.7%, 69.7%, 97.8%, and 71.9%, respectively, for the first surgical protocol (SV), the second (CR 1 × 1), the third (CR 1 × 3), and the fourth (PR 1 × 3). The appearance of malignant transformation after laser treatment (during the follow-up period of 6 years) was 20%, 1%, and 0.2%, respectively, for the groups treated by the following protocols: 1 (SV), 2 (CR 1 × 1), and 4 (PR 1 × 3). Only in the third group CR1x3, no dysplasia or malignant transformation was noted. On the contrary, the appearance of malignant transformation in failed treated cases was 21.21% for the protocol 1 (SV), 3% for the protocol 2 (CR 1 × 1), and 0.6% for the protocol 4 (PR 1 × 3).
CONCLUSIONS: The results of this long-term follow-up of treated patients with oral homogeneous leukoplakias pointed out that the surgical laser protocol respecting the complete excision of leukoplakias, in one session, by the removal of a minimum of 1 mm in lesion depth and 3 mm of surrounding healthy-like tissues (CR 1 × 3) offers significantly the highest success rate.
Research center :
d‐BRU - Dental Biomaterials Research Unit - ULiège [BE]
Disciplines :
Dentistry & oral medicine
Author, co-author :
Namour, Samir ; Université de Liège - ULiège > Département des sciences dentaires
Zeinoun, Toni; 2 Department of Oral and Maxillo-Facial Surgery, Faculty of Dentistry, Lebanese University , Beirut, and Rafic Hariri university, Hadath, Lebanon
Namour, Amaury; 1 Department of Dental Sciences, Faculty of Medicine, University of Liège , Liège, Belgium
Vanheusden, Alain ; Centre Hospitalier Universitaire de Liège - CHU > > Service prothèse fixée
Vescovi, Paolo; 3 Unit of Oral Pathology and Medicine and Laser-assisted Oral Surgery, Department of ENT/Dental/Ophthalmological and Cervico-Facial Sciences, Faculty of Medicine and Surgery, University of Parma , Parma, Italy
Language :
English
Title :
Evaluation of Different Laser-Supported Surgical Protocols for the Treatment of Oral Leukoplakia: A Long-Term Follow-Up.
Axell T, Pindborg JJ, Smith CJ, van der Waal I. Oral white lesions with special reference to precancerous and tobaccorelated lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21, 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 1996;25:49-54.
Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia an related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978;46:518-539.
Brouns ER, Baart JA, Bloemena E. The relevance of uniform reporting in oral leukoplakia: definition, certainty factor and staging based on experience with 275 patients. Med Oral Patol Oral Cir Bucal 2013;18:19-26.
Van der Waal I, Axell T. Oral leukoplakia: a proposal for uniform reporting. Oral Oncol 2002;38:521-526.
Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007;36:575-580.
Brennan M, Migliorati CA, Lockhart PB, et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103 Suppl:S19:1-12.
Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Systematic review of randomized trials for the treatment of oral leukoplakia. J Dent Educ 2002;66:896-902.
Waldron C, Shafer WG. Leukoplakia revisited. A clinicopathologic study of 3256 oral leukoplakias. Cancer 1975;36: 1386-1392.
Axell T. Occurrence of leukoplakia and some other oral white lesions among 20,333 adult Swedish people. Community Dent Oral Epidemiol 1987;15:46-51.
Reichart PA. Oral mucosal lesions in a representative crosssectional study of aging Germans. Community Dent Oral Epidemiol 2000;28:390-398.
Axell T, Holmstrup P, Kramer I, Pindborg JJ, Shear M. International seminar on oral leukoplakia and associated lesions related to tobacco habits. Community Dent Oral Epidemiol 1987;15:46-51.
Metha FS, Hamner JE. Tobacco-Related Oral Mucosal Lesions and Conditions in India. A Guide for Dental Students, Dentists and Physicians. Bombay: Basic Dental Research Unit, Tata Institute of Fundamental Research, 1993.
Dilhari A, Weerasekera MM, Siriwardhana A, et al. Candida infection in oral leukoplakia: an unperceived public health problem. Acta Odontol Scand 2016;74:565-569.
Johnson NW, Ranasinghe AW, Warnakulasuryia K. Potentially malignant lesions and conditions of the mouth and oropharynx: natural history-cellular and molecular markers of risk. Eur J Cancer Prev 1993;2:31-51.
Feller L, Lemmer J. Oral leukoplakia as it relates to HPV infection: a review. Int J Dent 2012;2012:540-561.
Bhosale PG, Pandey M, Desai RS, et al. Low prevalence of transcriptionally active human papilloma virus in Indian patients with HNSCC and leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol 2016;122:609-618.
Gupta PC, Mehta FS, Daftary DK, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villages. Community Dent Oral Epidemiol 1980;8:283-333.
Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol 2003;39:770-780.
Scheifele C, Reichart PA. Is there a natural limit of the transformation rate of oral leukoplakia? Oral Oncol 2003;39: 470-475.
Ishii J, Fujita K, Munemoto S, Komori T. Management of oral leukoplakia by laser surgery: relation between recurrence and malignant transformation and clinicopathological features. J Clin Laser Med Surg 2004;22:27-33.
Lodi G, Franchini R, Warnakulasuriya S, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev 2016;7. Art. No.: CD001829. doi: 10.1002/14651858.CD001829.pub4.
Ishii J, Fujiita K, Komori T. Laser surgery as a treatment for oral leukoplakia. Oral Oncol 2003;39:759-769.
Roodenburg JL, Panders AK, Vermey A. Carbon dioxide laser surgery of oral leukoplakia. Oral Surg Oral Med Oral Pathol 1991;71:670-674.
Chiesa F, Tradati N, Sala L, et al. Follow-up of oral leukoplakia after carbon dioxide laser surgery. Arch Otolaryngol Head Neck Surg 1990;116:177-190.
Pinheiro AL, Frame JW. Surgical management of premalignant lesions of the oral cavity with the CO2 laser. Braz Dent J 1996;7:103-108.
Gooris PJ, Roodenburg Jl, Vermey A, Nauta JM. Carbon dioxide laser evaporation of leukoplakia of the lower lip: a retrospective evaluation. Oral Oncol 1999;35:490-495.
Horch HH, Gerlach KL, Schaefer HE. CO2 laser surgery of oral premalignant lesions. Int J Oral maxillofac Surg 1986;15:19-24.
White JM, Chaudry SI, Kudler JJ, Sekandari N, Schoelch ML, Silverman S Jr. Nd:YAG and CO2 laser therapy of oral mucosal lesions. J Clin Laser Med Surg 1998;16;299-304.
Schwarz F, Maraki D, Yalcinkaya S, Bieling K, Bocking A, Becker J. Cytologic and DNA-cytometric follow-up of oral leukoplakia after CO2-and Er:YAG-laser assisted ablation: a pilot study. Lasers Surg Med 2005;37:29-36.
Marangoni O, Melato M, Longo L. 808-nm laser with exogenous chromophores for the treatment of benign oral lesions. Photomed Laser Surg 2005;23:324-327.
López-Jornet P, Camacho-Alonso F. Comparison of pain and swelling after removal of oral leukoplakia with CO2 laser and cold knife: a randomized clinical trial. Med Oral Patol Oral Cir Bucal 2013;18:38-44.
Van der Waal I, Schepman KP, van der Meij EH, Smeele LE. Oral leukoplakia: a clinicopathological review. Oral Oncol 1997;33:291-301.
Dosi T, Gupta D, Hazari A, Rajput R, Chauhan P, Rajapuri AS. Assessment of micronuclei frequency in individuals with a habit of tobacco by means of exfoliated oral buccal cells. J Int Soc Prev Community Dent 2016;6(Suppl 2):S143-S147.
Gopinath D, Thannikunnath BV, Neermunda SF. Prevalence of carcinomatous foci in oral leukoplakia: a clinicopathologic study of 546 Indian samples. J Clin Diagn Res 2016;10:ZC78-ZC83.
Warnakulasuriya S. Lack of molecular markers to predict malignant potential of oral precancer. J Pathol 2000;190: 407-409.
Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev 2006. Art. No.: CD001829. doi: 10.1002/14651858. CD001829.pub3.
Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003;14: 47-62.
Kuribayashi Y, Tsushima F, Morita K, et al. Long-term outcome of non-surgical treatment in patients with oral leukoplakia. Oral Oncol 2015;51:1020-1025.
Schepman KP, Van der Meij EH, Smeele LE, Van der Waal I. Malignant transformation of oral leukoplakia: a follow up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 1998; 34:270-275.
Namour S. Atlas of Current Oral Laser Surgery. USA: Universal Publishers, 2011.
Chiesa F, Boracchi P, Tradati N, et al. Risk of preneoplastic and neoplastic events in operated oral leukoplakias. Eur J Cancer B Oral Oncol 1993;29B:23-28.
Thomson PJ, Wylie J. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management. Int J Oral Maxillofac Surg 2002;31:145-153.
van der Hem PS, Nauta JM, van der Wal JE, Roodenburg JLN. The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up. Oral Oncol 2005;41:31-37.
Kuribayashi Y, Tsushima F, Sato M, Morita K, Omura K. Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy. J Oral Pathol Med 2012;41: 682-688.
Chainani-Wu N, Lee D, Madden E, Sim C, Collins K, Silverman S Jr. Clinical predictors of oral leukoplakia recurrence following CO2 laser vaporization. J Craniomaxillofac Surg 2015;43:1875-1879.
Del Corso G, Gissi DB, Tarsitano A, et al. Laser evaporation versus laser excision of oral leukoplakia: a retrospective study with long-term follow-up. J Craniomaxillofac Surg 2015; 43:763-768.
